Endocrine disruptor assessment list
Endocrine disruptor assessment list
Endocrine disruptor assessment list
ECHA’s endocrine disruptor (ED) assessment list includes the substances undergoing an ED assessment that have been brought for discussion to ECHA’s ED Expert Group.
Inclusion in the list means that an informal hazard assessment for endocrine-disrupting properties either is under development or has been completed since February 2013.
For each substance, the table shows the assessing or evaluating Member State (submitter), the outcome from the assessment, and the date of the latest update to the list entry.
Other process details and hazard assessment outcome documents are also available and can be accessed through the ‘Details’ icon.
One possible outcome of such an assessment is that a substance is considered not to have ED properties.
If the outcome is that the substance is considered to have ED properties, confirmation through the formal risk management and decision-making processes under is needed before any regulatory action can be taken due to these properties.
The intentions of authorities to submit a dossier to the formal REACH and CLP processes are notified through the Registry of Intentions. All biocidal active substances have to undergo a formal ED assessment. You can see the status of biocides assessments on the Biocidal Active Substances page.
The information and views set out in the ED assessment list and in the hazard assessment outcome documents are those of the evaluating authority and do not necessarily reflect the position or opinion of the other Member States or ECHA. Neither ECHA nor the evaluating authority nor any person acting on either of their behalves may be held liable for the use, which may be made of the information contained therein. Statements made or information contained in the documents are without prejudice to any formal regulatory activities that ECHA or the Member States may initiate at a later stage. ED assessments and their outcomes are compiled on the basis of information available by the date of the publication of the document.
Further information
- Understanding endocrine disruptor assessment
- ED Expert Group
- PACT
- Addressing substances of concern
- Registry of SVHC intentions until outcome
- Registry of restriction intentions until outcome
- Registry of CLH intentions until outcome
- Approval of active substances
- Biocidal active substances
- Biocidal Products Committee opinions
Last updated 14 October 2024. Database contains 127 unique substances/entries.
|
202-830-0
|
100-21-0
|
France
|
Concluded
|
not ED
|
11-Dec-2015
|
Details | |
|
201-067-0
|
77-90-7
|
France
|
Concluded
|
not ED
|
19-Dec-2016
|
Details | |
|
203-398-6
|
106-44-5
|
United Kingdom
|
Concluded
|
not ED
|
07-Mar-2017
|
Details | |
|
205-286-2
|
137-26-8
|
Sweden
|
Concluded
|
not ED
|
24-Oct-2018
|
Details | |
|
214-619-0
|
1166-46-7
|
Germany
|
Under development
|
Under development (BPR)
|
03-Feb-2021
|
Details | |
|
214-946-9
|
1222-05-5
|
France
|
Under development
|
Under development (other)
|
03-Feb-2021
|
Details | |
|
239-139-9
|
15087-24-8
|
Germany
|
Concluded
|
ED ENV
|
03-Feb-2021
|
Details | |
|
EC No. 216-133-4 and EC No. 244-240-6
show/hide
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one
EC / List no:
244-240-6
| CAS no:
21145-77-7
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one
EC / List no:
216-133-4
| CAS no:
1506-02-1
|
-
|
-
|
Germany
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details |
|
204-279-1
|
118-82-1
|
Austria
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details | |
|
201-236-9
|
79-94-7
|
Denmark
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details | |
|
202-532-0
|
96-76-4
|
Belgium
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details | |
|
204-881-4
|
128-37-0
|
France
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details | |
|
215-925-7
|
1453-58-3
|
Belgium
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details | |
|
ETHOFENPROX; TREBON
|
407-980-2
|
80844-07-1
|
Austria
|
Under development
|
Under development (BPR)
|
03-Feb-2021
|
Details |
|
201-245-8
|
80-05-7
|
Germany
|
Concluded
|
ED ENV
|
03-Feb-2021
|
Details | |
|
201-245-8
|
80-05-7
|
France
|
Concluded
|
ED HH
|
03-Feb-2021
|
Details | |
|
226-378-9
|
5384-21-4
|
France
|
Under development
|
Under development (other)
|
03-Feb-2021
|
Details | |
|
substances with a linear and/or branched alkyl chain with a carbon number of 7 covalently bound predominantly in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
show/hide
|
-
|
-
|
Austria
|
Concluded
|
ED ENV
|
03-Feb-2021
|
Details |
|
201-618-5
|
85-60-9
|
France
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details | |
|
202-525-2
|
96-69-5
|
Austria
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details | |
|
240-016-7
|
15879-93-3
|
Poland
|
Under development
|
Under development (BPR)
|
03-Feb-2021
|
Details | |
|
232-235-1
|
7790-98-9
|
Germany
|
Concluded
|
ED ENV
|
03-Feb-2021
|
Details | |
|
258-469-4
|
53306-54-0
|
Germany
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details | |
|
253-775-4
|
38083-17-9
|
Belgium
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details | |
|
231-159-6
|
7440-50-8
|
France
|
Under development
|
Under development (BPR)
|
03-Feb-2021
|
Details | |
|
613-953-8
|
66603-10-9
|
Austria
|
Under development
|
Under development (BPR)
|
03-Feb-2021
|
Details | |
|
201-545-9
|
84-61-7
|
Sweden
|
Concluded
|
ED HH
|
03-Feb-2021
|
Details | |
|
201-550-6
|
84-66-2
|
ECHA
|
Under development
|
Under development (other)
|
03-Feb-2021
|
Details | |
|
200-849-9
|
75-21-8
|
Norway
|
Under development
|
Under development (BPR)
|
03-Feb-2021
|
Details | |
|
202-785-7
|
99-76-3
|
France
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details | |
|
205-031-5
|
131-57-7
|
Denmark
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details | |
|
233-069-2
|
10028-15-6
|
Germany
|
Under development
|
Under development (BPR)
|
03-Feb-2021
|
Details | |
|
201-186-8
|
79-21-0
|
Austria
|
Under development
|
Under development (BPR)
|
03-Feb-2021
|
Details | |
|
310-154-3
|
121158-58-5
|
Germany
|
Concluded
|
ED ENV ED HH |
03-Feb-2021
|
Details | |
|
203-585-2
|
108-46-3
|
France
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details | |
|
203-585-2
|
108-46-3
|
Finland
|
Concluded
|
inconclusive
|
03-Feb-2021
|
Details | |
|
203-585-2
|
108-46-3
|
France
|
Under development
|
Under development (other)
|
03-Feb-2021
|
Details | |
|
868-573-7
|
130328-19-7
|
Sweden
|
Under development
|
Under development (BPR)
|
03-Feb-2021
|
Details | |
|
ALPHASAN ANTIMICROBIAL RC 2000; ALPHASAN ANTIMICROBIAL RC 5000; NOVARON; SILVER SODIUM HYDROGEN ZIRCONIUM PHOSPHATE
|
422-570-3
|
155925-27-2
|
Sweden
|
Under development
|
Under development (BPR)
|
03-Feb-2021
|
Details |
|
603-404-0
|
130328-20-0
|
Sweden
|
Under development
|
Under development (BPR)
|
03-Feb-2021
|
Details | |
|
231-511-9
|
7601-89-0
|
Germany
|
Concluded
|
ED ENV
|
03-Feb-2021
|
Details | |
|
231-195-2
|
7446-09-5
|
Germany
|
Under development
|
Under development (BPR)
|
03-Feb-2021
|
Details | |
|
212-950-5
|
886-50-0
|
Slovakia
|
Under development
|
Under development (BPR)
|
03-Feb-2021
|
Details | |
|
231-711-6
|
7696-12-0
|
Germany
|
Under development
|
Under development (BPR)
|
03-Feb-2021
|
Details | |
|
201-071-2
|
77-94-1
|
France
|
Under development
|
Under development (other)
|
03-Feb-2021
|
Details | |
|
222-182-2
|
3380-34-5
|
Denmark
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details | |
|
222-020-0
|
3319-31-1
|
Austria
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details | |
|
205-288-3
|
137-30-4
|
Denmark
|
Under development under SEV
|
Under development (SEV)
|
03-Feb-2021
|
Details | |
|
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Chrysanthemum cinerariaefolium, Compositae.
|
289-699-3
|
89997-63-7
|
Spain
|
Under development
|
Under development (BPR)
|
05-Feb-2021
|
Details |
|
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Chrysanthemum cinerariaefolium, Compositae.
|
289-699-3
|
89997-63-7
|
Spain
|
Under development
|
Under development (BPR)
|
05-Feb-2021
|
Details |